Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 65Neoplasms 56Prostatic Neoplasms 44Lung Neoplasms 35Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 24Pancreatic Neoplasms 21Hematologic Neoplasms 19Head and Neck Neoplasms 16Neoplasm Metastasis 15Urinary Bladder Neoplasms 12Ovarian Neoplasms 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Motor Activity 10Triple Negative Breast Neoplasms 9Multiple Myeloma 9Colonic Neoplasms 9Melanoma 8Glioma 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Glioblastoma 7Gastrointestinal Neoplasms 7Esophageal Neoplasms 7Anatomic Stage I Breast Cancer AJCC v8 7Smoking Cessation 6Sarcoma 6Rectal Neoplasms 6

Interventions

fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3Curcumin 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cyclosporine 2Busulfan 2Biopsy 2Antilymphocyte Serum 2pyroxamide 1piperine 1liposomal amphotericin B 1isatuximab 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Urination 1Topotecan 1Tissue Banks 1Therapeutics 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Monoclonal Gammopathy of Undetermined Significance × Standard of Care × Clear all
NCT04439006 2023-12-26

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
10 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡